2.10

4.11% -0.09

Entera Bio Ltd (ENTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.19

Offen:

$2.16

24-Stunden-Volumen:

29,997

Relative Volume:

0.21

Marktkapitalisierung:

$77.35M

Einnahmen:

$134.00K

Nettoeinkommen (Verlust:

$-9.93M

KGV:

-6.1765

EPS:

-0.34

Netto-Cashflow:

$-6.72M

1W Leistung:

-13.58%

1M Leistung:

-12.50%

6M Leistung:

+27.27%

1J Leistung:

+100.00%

1-Tages-Spanne:

$2.05

$2.22

1-Wochen-Bereich:

$2.05

$2.49

52-Wochen-Spanne:

$0.9453

$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Firmenname

Entera Bio Ltd

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

972-2-532-7151

Adresse

KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

ENTX's Discussions on Twitter

Vergleichen Sie ENTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ENTX Entera Bio Ltd	2.10	77.35M	134.00K	-9.93M	-6.72M	-0.34
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-03-22	Eingeleitet	Aegis Capital	Buy

Entera Bio Ltd Aktie (ENTX) Neueste Nachrichten

Feb 19, 2025

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskel - The Manila Times

Feb 19, 2025

Could This Oral Osteoporosis Treatment Replace Daily Injections? Phase 2 Data Reveals Promising Results - StockTitan

Feb 19, 2025

Feb 17, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 31.6% in January - MarketBeat

Feb 17, 2025

Feb 07, 2025

US Penny Stocks: 3 Picks With Market Caps Over $60M - Yahoo Finance

Feb 07, 2025

Feb 06, 2025

Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Feb 06, 2025

Feb 04, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Feb 04, 2025

Feb 03, 2025

145,843 Shares in Entera Bio Ltd. (NASDAQ:ENTX) Acquired by Perigon Wealth Management LLC - MarketBeat

Feb 03, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 23.1% in January - MarketBeat

Feb 03, 2025

Jan 27, 2025

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Jan 27, 2025

Entera Bio CEO to Present Business Updates at Oppenheimer Healthcare Conference - StockTitan

Jan 27, 2025

Jan 18, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Decrease in Short Interest - Defense World

Jan 18, 2025

Jan 10, 2025

Entera Bio files Exhibit 5.1 with SEC By Investing.com - Investing.com South Africa

Jan 10, 2025

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Simply Wall St

Dec 07, 2024

Dec 01, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Rises By 19.0% - MarketBeat

Dec 01, 2024

Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024

Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024

Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024

Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat

Nov 11, 2024

Nov 08, 2024